Virtus Advisers LLC Invests $888,000 in Prestige Consumer Healthcare Inc. $PBH

Virtus Advisers LLC bought a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,324 shares of the company’s stock, valued at approximately $888,000. Prestige Consumer Healthcare comprises about 1.2% of Virtus Advisers LLC’s portfolio, making the stock its 16th largest holding.

A number of other hedge funds have also modified their holdings of PBH. Kayne Anderson Rudnick Investment Management LLC purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth approximately $84,932,000. Invesco Ltd. grew its position in shares of Prestige Consumer Healthcare by 24.7% during the first quarter. Invesco Ltd. now owns 1,321,800 shares of the company’s stock worth $113,635,000 after acquiring an additional 261,537 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Prestige Consumer Healthcare by 1,073.3% during the fourth quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company’s stock worth $15,923,000 after purchasing an additional 186,524 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Prestige Consumer Healthcare by 11,580.3% during the first quarter. GAMMA Investing LLC now owns 161,538 shares of the company’s stock worth $13,887,000 after purchasing an additional 160,155 shares during the period. Finally, Neumeier Poma Investment Counsel LLC acquired a new stake in shares of Prestige Consumer Healthcare during the first quarter worth $8,713,000. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock opened at $66.7550 on Monday. Prestige Consumer Healthcare Inc. has a one year low of $62.95 and a one year high of $90.04. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. The business has a fifty day moving average of $75.29 and a two-hundred day moving average of $81.18. The company has a market cap of $3.29 billion, a P/E ratio of 15.67, a price-to-earnings-growth ratio of 2.11 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The business had revenue of $249.53 million during the quarter, compared to analyst estimates of $260.71 million. During the same period last year, the business posted $0.90 EPS. Prestige Consumer Healthcare’s revenue was down 6.6% compared to the same quarter last year. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on PBH shares. Royal Bank Of Canada raised Prestige Consumer Healthcare to a “hold” rating in a report on Thursday, May 8th. Canaccord Genuity Group decreased their price target on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating for the company in a report on Friday, August 8th. Finally, Wall Street Zen downgraded Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Three investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and an average target price of $93.33.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.